Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Clin Chim Acta. 2018 Dec;487:293-298. doi: 10.1016/j.cca.2018.10.013. Epub 2018 Oct 5.
Biotinylated antibodies and analogues are currently used in many immunoassays while biotin is widely used as a dietary supplement. Thus, biotin interference is an emerging issue for clinical laboratories.
Various concentrations of biotin solutions were prepared using pooled patient serum samples. All analytes were measured by sandwich or competitive immunoassay on the Roche Cobas 8000 e602 platform.
Some of the sandwich immunoassay results were falsely decreased to different extents by different biotin levels, while some of the competitive immunoassay results were falsely increased. The most notable false reductions were in high-sensitivity troponin T, thyroid-stimulating hormone, and follicle-stimulating hormone results, while the most notable false increases were in triiodothyronine and vitamin D results. Other immunoassay results were also affected to some extent by biotin interference.
Biotin can interfere in immunoassays and result in aberrant test results. Clinicians should use caution in interpreting abnormal results in patients who ingest biotin.
生物素化抗体和类似物目前广泛应用于许多免疫分析中,而生物素则被广泛用作膳食补充剂。因此,生物素干扰是临床实验室面临的一个新问题。
使用混合患者血清样本制备了不同浓度的生物素溶液。所有分析物均在罗氏 Cobas 8000 e602 平台上通过夹心或竞争免疫分析法进行测量。
不同浓度的生物素会导致某些夹心免疫分析结果不同程度的假性降低,而某些竞争免疫分析结果则会假性升高。最显著的假性降低发生在高敏肌钙蛋白 T、促甲状腺激素和卵泡刺激素结果中,而最显著的假性升高则发生在三碘甲状腺原氨酸和维生素 D 结果中。其他免疫分析结果也受到生物素干扰的一定程度影响。
生物素可干扰免疫分析并导致检测结果异常。临床医生在解释摄入生物素的患者的异常结果时应谨慎。